Phase 3 clinical trial of investigational vaccine for COVID-19 began
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
On Jul. 21, 2020, researchers announced they were working to develop a safe and effective vaccine against SARS-CoV-2,…
On Jul. 20, 2020, Luminex announced the Food and Drug Administration (FDA) had issued an Emergency Use Authorization…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesメ four investigational vaccine candidates from…
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
On Jun. 5, 2020, results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK)…
On Jun. 4, 2020, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specified…
On May 28, 2020, the Jenner Institute, University of Oxford, UK and Advent Srl ヨ an IRBM company,…
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
On May 12, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) had issued an Emergency Use…
On May 9, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…
On May 4, 2020, Junshi Biosciences and Eli Lilly announced they have entered into an agreement to co-develop therapeutic…
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
On Apr. 30, 2020, AstraZeneca and the University of Oxford announced an agreement for the global development and…
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
On Apr. 29, 2020, the U.S. Dep. of Veterans Affairs (VA) announced a partnership with the XPRIZE Foundationメs…
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaᆴ molecular assay to detect…
On Apr. 27, 2020, Mateon Therapeutics announced announced it has submitted an Investigational New Drug application to the…
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
On Apr. 27, 2020, LabCorpᆴ announced that it will offer antibody tests for the virus that causes COVID-19….
On Apr. 27, 2020, a novel means to prevent HIV infection was developed at the University of Nebraska…
On Apr. 27, 2020, Diffusion Pharmaceuticals announced the pre-IND submission to the FDA of a planned clinical program…
On Apr. 24, 2020, a new study led by researchers at Oxford and Guangdong Centre for Diseases Control…
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…